Published in Hum Mol Genet on December 01, 2010
Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy. PLoS One (2012) 0.97
Dysferlin interacts with histone deacetylase 6 and increases alpha-tubulin acetylation. PLoS One (2011) 0.96
Myoferlin depletion in breast cancer cells promotes mesenchymal to epithelial shape change and stalls invasion. PLoS One (2012) 0.95
Lysosome fusion to the cell membrane is mediated by the dysferlin C2A domain in coronary arterial endothelial cells. J Cell Sci (2012) 0.95
The intracellular Ca²⁺ channel MCOLN1 is required for sarcolemma repair to prevent muscular dystrophy. Nat Med (2014) 0.94
Dysferlin regulates cell membrane repair by facilitating injury-triggered acid sphingomyelinase secretion. Cell Death Dis (2014) 0.94
Membrane Repair: Mechanisms and Pathophysiology. Physiol Rev (2015) 0.88
Dysferlin-deficient immortalized human myoblasts and myotubes as a useful tool to study dysferlinopathy. PLoS Curr (2012) 0.87
EHD1 mediates vesicle trafficking required for normal muscle growth and transverse tubule development. Dev Biol (2014) 0.87
Rapid actin-cytoskeleton-dependent recruitment of plasma membrane-derived dysferlin at wounds is critical for muscle membrane repair. FASEB J (2014) 0.86
An actin-dependent annexin complex mediates plasma membrane repair in muscle. J Cell Biol (2016) 0.85
Dysferlin and myoferlin regulate transverse tubule formation and glycerol sensitivity. Am J Pathol (2013) 0.84
Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response. Neuromuscul Disord (2012) 0.84
Targeted analysis of whole genome sequence data to diagnose genetic cardiomyopathy. Circ Cardiovasc Genet (2014) 0.82
Membrane damage-induced vesicle-vesicle fusion of dysferlin-containing vesicles in muscle cells requires microtubules and kinesin. Hum Mol Genet (2013) 0.81
Membrane fusion in muscle development and repair. Semin Cell Dev Biol (2015) 0.79
Plasma Membrane Repair: A Central Process for Maintaining Cellular Homeostasis. Physiology (Bethesda) (2015) 0.79
Trophoblast cell fusion and differentiation are mediated by both the protein kinase C and a pathways. PLoS One (2013) 0.78
Multifaceted role of insulin-like growth factors and mammalian target of rapamycin in skeletal muscle. Endocrinol Metab Clin North Am (2012) 0.78
Enhanced Muscular Dystrophy from Loss of Dysferlin Is Accompanied by Impaired Annexin A6 Translocation after Sarcolemmal Disruption. Am J Pathol (2016) 0.77
Dynamin 2 the rescue for centronuclear myopathy. J Clin Invest (2014) 0.77
Upregulated IL-1β in dysferlin-deficient muscle attenuates regeneration by blunting the response to pro-inflammatory macrophages. Skelet Muscle (2015) 0.76
Exon 32 Skipping of Dysferlin Rescues Membrane Repair in Patients' Cells. J Neuromuscul Dis (2015) 0.75
GRAF1 deficiency blunts sarcolemmal injury repair and exacerbates cardiac and skeletal muscle pathology in dystrophin-deficient mice. Skelet Muscle (2015) 0.75
Plasma Membrane Repair in Health and Disease. Curr Top Membr (2015) 0.75
Co-expression of truncated and full-length tau induces severe neurotoxicity. Mol Psychiatry (2016) 0.75
Dysferlinopathy Fibroblasts Are Defective in Plasma Membrane Repair. PLoS Curr (2015) 0.75
Muscle cell communication in development and repair. Curr Opin Pharmacol (2017) 0.75
Treatment with Recombinant Human MG53 Protein Increases Membrane Integrity in a Mouse Model of Limb Girdle Muscular Dystrophy 2B. Mol Ther (2017) 0.75
Cellular and molecular regulation of muscle regeneration. Physiol Rev (2004) 10.72
Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell (1993) 10.36
Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature (2003) 6.50
Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet (1998) 4.38
Maturation of autophagic vacuoles in Mammalian cells. Autophagy (2005) 4.08
A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet (1998) 3.76
Functional expression of the human transferrin receptor cDNA in Chinese hamster ovary cells deficient in endogenous transferrin receptor. J Cell Biol (1987) 3.28
IGF-I is required for normal embryonic growth in mice. Genes Dev (1993) 3.17
Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem (1995) 2.95
Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. Hum Mol Genet (2004) 2.32
Role of LAMP-2 in lysosome biogenesis and autophagy. Mol Biol Cell (2002) 2.25
Cell biology of Ca2+-triggered exocytosis. Curr Opin Cell Biol (2010) 2.15
mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci (1995) 2.06
Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol (2001) 2.05
Normal myoblast fusion requires myoferlin. Development (2005) 1.97
The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol (1988) 1.96
Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains. J Biol Chem (2002) 1.73
Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet (1999) 1.69
The organogenesis of murine striated muscle: a cytoarchitectural study. Am J Anat (1984) 1.65
Dense-core secretory granule biogenesis. Physiology (Bethesda) (2006) 1.62
Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients. Neurology (2001) 1.60
The endocytic recycling protein EHD2 interacts with myoferlin to regulate myoblast fusion. J Biol Chem (2008) 1.45
Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophy. Hum Mol Genet (1996) 1.39
Dynamics of nuclei of muscle fibers and connective tissue cells in normal and denervated rat muscles. Muscle Nerve (2000) 1.39
Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy. Hum Mol Genet (2009) 1.37
IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice. Neuromuscul Disord (2001) 1.29
Otoferlin is a calcium sensor that directly regulates SNARE-mediated membrane fusion. J Cell Biol (2010) 1.28
Characterization of lipid binding specificities of dysferlin C2 domains reveals novel interactions with phosphoinositides. Biochemistry (2009) 1.23
Absence of dysferlin alters myogenin expression and delays human muscle differentiation "in vitro". J Biol Chem (2006) 1.20
Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation. Am J Med Genet (2000) 1.17
Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy. Am J Pathol (2009) 1.08
The third human FER-1-like protein is highly similar to dysferlin. Genomics (2000) 1.06
Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults. Mech Ageing Dev (2008) 1.05
Preferential enhancement of myoblast differentiation by insulin-like growth factors (IGF I and IGF II) in primary cultures of chicken embryonic cells. FEBS Lett (1983) 1.03
Myoferlin is required for insulin-like growth factor response and muscle growth. FASEB J (2009) 0.99
Comparison of the kinetics of cycling of the transferrin receptor in the presence or absence of bound diferric transferrin. Biochem J (1989) 0.96
Organogenesis of the mouse extensor digitorum logus muscle: a quantitative study. Am J Anat (1984) 0.94
Spontaneous coronary vasospasm in KATP mutant mice arises from a smooth muscle-extrinsic process. Circ Res (2006) 2.64
Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am J Pathol (2005) 2.45
The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res (2004) 2.29
Nesprin-1alpha self-associates and binds directly to emerin and lamin A in vitro. FEBS Lett (2002) 2.24
Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels. J Clin Invest (2002) 2.11
Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies. Annu Rev Physiol (2009) 2.03
Myne-1, a spectrin repeat transmembrane protein of the myocyte inner nuclear membrane, interacts with lamin A/C. J Cell Sci (2002) 2.02
Population-based variation in cardiomyopathy genes. Circ Cardiovasc Genet (2012) 2.00
Normal myoblast fusion requires myoferlin. Development (2005) 1.97
Disruption of nesprin-1 produces an Emery Dreifuss muscular dystrophy-like phenotype in mice. Hum Mol Genet (2008) 1.83
Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy. J Am Coll Cardiol (2010) 1.83
The genetics of dilated cardiomyopathy. Curr Opin Cardiol (2010) 1.76
Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains. J Biol Chem (2002) 1.73
Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice. J Clin Invest (2009) 1.67
Age-dependent effect of myostatin blockade on disease severity in a murine model of limb-girdle muscular dystrophy. Am J Pathol (2006) 1.64
LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy. Ann Neurol (2013) 1.63
Functional nitric oxide synthase mislocalization in cardiomyopathy. J Mol Cell Cardiol (2004) 1.58
DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis. Cancer Res (2010) 1.49
Nesprin-1 mutations in human and murine cardiomyopathy. J Mol Cell Cardiol (2009) 1.48
Muscle diseases: the muscular dystrophies. Annu Rev Pathol (2007) 1.47
The endocytic recycling protein EHD2 interacts with myoferlin to regulate myoblast fusion. J Biol Chem (2008) 1.45
Undifferentiated intimal sarcoma of large systemic blood vessels: report of 14 cases with immunohistochemical profile and review of the literature. Am J Surg Pathol (2005) 1.40
S100A12 mediates aortic wall remodeling and aortic aneurysm. Circ Res (2009) 1.36
Interferon-gamma induced medulloblastoma in the developing cerebellum. J Neurosci (2004) 1.35
Genetic background influences muscular dystrophy. Neuromuscul Disord (2005) 1.34
Nesprin-1alpha contributes to the targeting of mAKAP to the cardiac myocyte nuclear envelope. Exp Cell Res (2005) 1.34
S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program. Arterioscler Thromb Vasc Biol (2010) 1.32
Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy. Trends Cardiovasc Med (2007) 1.30
Reduced life span with heart and muscle dysfunction in Drosophila sarcoglycan mutants. Hum Mol Genet (2007) 1.28
Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle. J Clin Invest (2004) 1.23
Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-β pathway. Proc Natl Acad Sci U S A (2012) 1.23
Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges. Semin Oncol (2011) 1.21
Cardiac assessment in duchenne and becker muscular dystrophies. Curr Heart Fail Rep (2010) 1.21
Repairing the tears: dysferlin in muscle membrane repair. Trends Mol Med (2003) 1.21
Genetic compensation for sarcoglycan loss by integrin alpha7beta1 in muscle. J Cell Sci (2004) 1.19
Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function. J Biol Chem (2007) 1.19
Myostatin blockade improves function but not histopathology in a murine model of limb-girdle muscular dystrophy 2C. Muscle Nerve (2008) 1.17
Smooth muscle cell-extrinsic vascular spasm arises from cardiomyocyte degeneration in sarcoglycan-deficient cardiomyopathy. J Clin Invest (2004) 1.14
Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development. Dev Dyn (2010) 1.13
Sulfonylurea receptor-dependent and -independent pathways mediate vasodilation induced by ATP-sensitive K+ channel openers. Mol Pharmacol (2008) 1.13
Mice lacking sulfonylurea receptor 2 (SUR2) ATP-sensitive potassium channels are resistant to acute cardiovascular stress. J Mol Cell Cardiol (2007) 1.13
Cardiac sulfonylurea receptor short form-based channels confer a glibenclamide-insensitive KATP activity. J Mol Cell Cardiol (2007) 1.12
Molecular identification and functional characterization of a mitochondrial sulfonylurea receptor 2 splice variant generated by intraexonic splicing. Circ Res (2009) 1.12
SMAD signaling drives heart and muscle dysfunction in a Drosophila model of muscular dystrophy. Hum Mol Genet (2010) 1.10
Altered chromosomal positioning, compaction, and gene expression with a lamin A/C gene mutation. PLoS One (2010) 1.08
Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy. Am J Pathol (2009) 1.08
Sarcomere mutations in cardiomyopathy with left ventricular hypertrabeculation. Circ Cardiovasc Genet (2009) 1.07
Advocacy: yes we can. J Clin Invest (2012) 1.07
Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair. Proc Natl Acad Sci U S A (2014) 1.07
TBX5 drives Scn5a expression to regulate cardiac conduction system function. J Clin Invest (2012) 1.06
Endocytic recycling proteins EHD1 and EHD2 interact with fer-1-like-5 (Fer1L5) and mediate myoblast fusion. J Biol Chem (2010) 1.05
Distinct genetic regions modify specific muscle groups in muscular dystrophy. Physiol Genomics (2010) 1.05
Ets1 is required for proper migration and differentiation of the cardiac neural crest. Development (2010) 1.04
Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy. J Am Coll Cardiol (2006) 1.04
Mechanisms of muscle weakness in muscular dystrophy. J Gen Physiol (2010) 1.03
Processing and assembly of the dystrophin glycoprotein complex. Traffic (2007) 1.01
Emery-Dreifuss muscular dystrophy. Handb Clin Neurol (2011) 1.01
Zeta-sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy. Hum Mol Genet (2002) 1.01
Genetic disruption of calcineurin improves skeletal muscle pathology and cardiac disease in a mouse model of limb-girdle muscular dystrophy. J Biol Chem (2007) 1.00
Myoferlin is required for insulin-like growth factor response and muscle growth. FASEB J (2009) 0.99
Ferlin proteins in myoblast fusion and muscle growth. Curr Top Dev Biol (2011) 0.98
Hydrogen sulfide dilates cerebral arterioles by activating smooth muscle cell plasma membrane KATP channels. Am J Physiol Heart Circ Physiol (2011) 0.96
Lamin A/C truncation in dilated cardiomyopathy with conduction disease. BMC Med Genet (2003) 0.96
Translational control of FOG-2 expression in cardiomyocytes by microRNA-130a. PLoS One (2009) 0.96
The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence. Expert Rev Neurother (2015) 0.96
S100A12 expression in thoracic aortic aneurysm is associated with increased risk of dissection and perioperative complications. J Am Coll Cardiol (2012) 0.95
Duchenne muscular dystrophy: how bad is the heart? Heart (2008) 0.95
Modifying muscular dystrophy through transforming growth factor-β. FEBS J (2013) 0.95
Fog1 is required for cardiac looping in zebrafish. Dev Biol (2005) 0.95
Genetic pathways of vascular calcification. Trends Cardiovasc Med (2012) 0.94
Cardiomyopathy is independent of skeletal muscle disease in muscular dystrophy. FASEB J (2002) 0.94
Nuclear sequestration of delta-sarcoglycan disrupts the nuclear localization of lamin A/C and emerin in cardiomyocytes. Hum Mol Genet (2006) 0.93
Exon-skipping therapy: a roadblock, detour, or bump in the road? Sci Transl Med (2014) 0.92
Genetic modifiers of muscular dystrophy: implications for therapy. Biochim Biophys Acta (2006) 0.91
Secondary coronary artery vasospasm promotes cardiomyopathy progression. Am J Pathol (2004) 0.91
FOG-2 attenuates endothelial-to-mesenchymal transformation in the endocardial cushions of the developing heart. Dev Biol (2006) 0.91
The superhealing MRL background improves muscular dystrophy. Skelet Muscle (2012) 0.90
Gene expression, chromosome position and lamin A/C mutations. Nucleus (2011) 0.90
Site-specific effects of peptide lipidation on beta-amyloid aggregation and cytotoxicity. J Biol Chem (2007) 0.89